Monica Feole
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Monica Feole has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Victorio Martin Pozo Devoto
Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina
6 shared publications - Gorazd Bernard Stokin
Palacký University Olomouc
5 shared publications - Dasa Bohaciakova
Department of Histology and Embryology, Faculty of Medicine Masaryk University Brno Czech Republic
2 shared publications - Hana Hribkova
Faculty of Medicine, Department of Histology and Embryology Masaryk University Brno Czech Republic
2 shared publications - Jan Raska
Faculty of Medicine, Department of Histology and Embryology Masaryk University Brno Czech Republic
2 shared publications - Jiri Sedmik
Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, Brno 625 00, Czech Republic
2 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (8)
SORL1 variant links endosomal amyloid precursor protein mis‐sorting to axonal transport defects and neuronal dysfunction
INTRODUCTION: SORL1 encodes the sorting receptor SORLA, a major genetic contributor to Alzheimer's disease (AD). Although SORL1 loss disrupts endosomal trafficking and promotes amyloidogenic amyloid precursor protein (APP) processing, the functional consequences of specific missense variants in human neurons remain unclear. METHODS: We used isogenic induced pluripotent stem cell (iPSC)‐derived NGN2 neurons and 3D cerebral organoids carrying wild‐type, SORL1 p.Y1816C knock‐in, or SORL1 knockout alleles. We analyzed SORLA maturation and shedding, APP localization, amyloid‐β (Aβ) secretion, endosomal morphology, axonal transport of Rab5+ endosomes and APP, and network activity. RESULTS: The p.Y1816C variant impaired SORLA maturation and shedding and, together with knockout, caused enlarged early endosomes, APP retention, elevated Aβ secretion, amyloid deposition in organoids, axonal swellings, disrupted axonal transport, and neuronal hyperexcitability. CONCLUSIONS: The SORL1 p.Y1816C variant is pathogenic in human neurons, and we reveal novel roles for SORLA in axonal transport and neuronal excitability. These findings highlight endosomal trafficking disruption as a central mechanism in AD pathogenesis.
- 22 August 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (8)
Open AccessSORL1 variant links endosomal amyloid precursor protein mis‐sorting to axonal transport defects and neuronal dysfunction
INTRODUCTION: SORL1 encodes the sorting receptor SORLA, a major genetic contributor to Alzheimer's disease (AD). Although SORL1 loss disrupts endosomal trafficking and promotes amyloidogenic amyloid precursor protein (APP) processing, the functional consequences of specific missense variants in human neurons remain unclear. METHODS: We used isogenic induced pluripotent stem cell (iPSC)‐derived NGN2 neurons and 3D cerebral organoids carrying wild‐type, SORL1 p.Y1816C knock‐in, or SORL1 knockout alleles. We analyzed SORLA maturation and shedding, APP localization, amyloid‐β (Aβ) secretion, endosomal morphology, axonal transport of Rab5+ endosomes and APP, and network activity. RESULTS: The p.Y1816C variant impaired SORLA maturation and shedding and, together with knockout, caused enlarged early endosomes, APP retention, elevated Aβ secretion, amyloid deposition in organoids, axonal swellings, disrupted axonal transport, and neuronal hyperexcitability. CONCLUSIONS: The SORL1 p.Y1816C variant is pathogenic in human neurons, and we reveal novel roles for SORLA in axonal transport and neuronal excitability. These findings highlight endosomal trafficking disruption as a central mechanism in AD pathogenesis.
- Open Access
Multiple motor proteins regulate ALS-linked TDP-43 anterograde axonal transport
TDP-43 is an RNA-binding protein essential for RNA metabolism. Under physiological conditions, it predominantly resides in the nucleus but is also expressed in the cytoplasm, where it regulates mRNA trafficking and local translation. In nearly 97% of Amyotrophic Lateral Sclerosis (ALS) cases, TDP-43 undergoes nuclear depletion and cytoplasmic aggregation. While its nuclear functions are well characterized, its axonal roles remain poorly understood, despite axonal degeneration being a hallmark of ALS pathology. To address this gap, we investigated TDP-43 localization and transport dynamics in axons of H9-derived human neurons. We compared fluorescently labeled TDP-43 with three well-characterized axonal cargoes, Rab5, synaptophysin, and APP, and examined protein-protein interactions between TDP-43 and the axonal transport machinery. Our analyses revealed that TDP-43 exhibits active anterograde axonal transport and interacts with multiple kinesin motor proteins, including all three KIF5 isoforms, through the adaptor KLC1, and the synaptic vesicles motor KIF1A. This multi-motor engagement suggests a flexible transport system that ensures mRNA delivery to distal axons. In ALS, where TDP-43 accumulates abnormally in the cytoplasm, this flexibility may become compromised, with multiple transport mechanisms simultaneously affected. This could contribute to progressive accumulation of non-functional TDP-43 granules, disrupting mRNA trafficking and local translation. Our findings provide a foundation for understanding how physiological TDP-43 transport mechanisms may be impaired during disease, highlighting axonal TDP-43 transport pathways as potential therapeutic targets.
Open AccessMultiple motor proteins regulate ALS-linked TDP-43 anterograde axonal transport
TDP-43 is an RNA-binding protein essential for RNA metabolism. Under physiological conditions, it predominantly resides in the nucleus but is also expressed in the cytoplasm, where it regulates mRNA trafficking and local translation. In nearly 97% of Amyotrophic Lateral Sclerosis (ALS) cases, TDP-43 undergoes nuclear depletion and cytoplasmic aggregation. While its nuclear functions are well characterized, its axonal roles remain poorly understood, despite axonal degeneration being a hallmark of ALS pathology. To address this gap, we investigated TDP-43 localization and transport dynamics in axons of H9-derived human neurons. We compared fluorescently labeled TDP-43 with three well-characterized axonal cargoes, Rab5, synaptophysin, and APP, and examined protein-protein interactions between TDP-43 and the axonal transport machinery. Our analyses revealed that TDP-43 exhibits active anterograde axonal transport and interacts with multiple kinesin motor proteins, including all three KIF5 isoforms, through the adaptor KLC1, and the synaptic vesicles motor KIF1A. This multi-motor engagement suggests a flexible transport system that ensures mRNA delivery to distal axons. In ALS, where TDP-43 accumulates abnormally in the cytoplasm, this flexibility may become compromised, with multiple transport mechanisms simultaneously affected. This could contribute to progressive accumulation of non-functional TDP-43 granules, disrupting mRNA trafficking and local translation. Our findings provide a foundation for understanding how physiological TDP-43 transport mechanisms may be impaired during disease, highlighting axonal TDP-43 transport pathways as potential therapeutic targets.
- Open Access
The Alzheimer’s-Associated SORL1 p.Y1816C Variant Impairs APP Sorting, Axonal Trafficking, and Neuronal Activity in iPSC-Derived Brain Models
Background: SORL1 , encoding the sorting receptor SORLA, is now recognized as the fourth autosomal dominant Alzheimer’s disease (AD) gene. Loss of SORLA function is known to disrupt endosomal trafficking and enhance amyloidogenic APP processing, two key aspects of the onset and progression of AD. However, the pathogenic consequences of disrupted endolysosomal pathways, deregulated protein sorting, as well as the effects of specific SORL1 missense variants on human neuronal function, still remain understudied. Methods: Our investigations were performed using two complementary human iPSC-derived models: 2D NGN2-induced neurons and 3D cerebral organoids established from isogenic wild-type (WT), SORL1 p.Y1816C (KI) missense variant, and SORL1 knock-out (KO) cells. We analyzed SORLA maturation and ectodomain shedding, APP localization, and amyloid-β secretion. Endosomal morphology and neuritic swellings were assessed via electron microscopy, while axonal transport of APP and Rab5+ endosomes was evaluated through live-cell imaging. Neuronal network activity was measured using multielectrode array recordings. Results: Our results demonstrate that the p.Y1816C variant leads to impaired SORLA maturation and reduced shedding, without affecting neuronal or organoid differentiation. Notably, we show an ultrastructure of endosomes, including their content, and demonstrate that both KO and KI models exhibit early endosome enlargement, increased APP retention in endosomes, elevated Aβ40/42 secretion, and amyloid-β deposition in 3D organoids. Importantly, we identified previously uncharacterized functional consequences of abolished SORLA activity, including axonal swellings and significantly impaired transport of Rab5+ endosomes and APP, characterized by deregulated velocities, directionality of transport, and increased stalling. Additionally, we discovered that both KO and p.Y1816C KI neurons exhibit abnormal electrophysiological activity, including increased spontaneous firing, burst frequency, and network synchrony. Conclusions: Our study defines the mechanistic consequences of the SORL1 p.Y1816C variant and demonstrates its pathogenicity in human neurons. Importantly, we also identify novel roles for SORLA in maintaining axonal transport homeostasis and regulating neuronal excitability, expanding its functional relevance beyond endosomal APP processing. These findings reinforce the central role of endosomal trafficking disruption in AD and support the use of isogenic human models for evaluating AD risk variants.
Open AccessThe Alzheimer’s-Associated SORL1 p.Y1816C Variant Impairs APP Sorting, Axonal Trafficking, and Neuronal Activity in iPSC-Derived Brain Models
Background: SORL1 , encoding the sorting receptor SORLA, is now recognized as the fourth autosomal dominant Alzheimer’s disease (AD) gene. Loss of SORLA function is known to disrupt endosomal trafficking and enhance amyloidogenic APP processing, two key aspects of the onset and progression of AD. However, the pathogenic consequences of disrupted endolysosomal pathways, deregulated protein sorting, as well as the effects of specific SORL1 missense variants on human neuronal function, still remain understudied. Methods: Our investigations were performed using two complementary human iPSC-derived models: 2D NGN2-induced neurons and 3D cerebral organoids established from isogenic wild-type (WT), SORL1 p.Y1816C (KI) missense variant, and SORL1 knock-out (KO) cells. We analyzed SORLA maturation and ectodomain shedding, APP localization, and amyloid-β secretion. Endosomal morphology and neuritic swellings were assessed via electron microscopy, while axonal transport of APP and Rab5+ endosomes was evaluated through live-cell imaging. Neuronal network activity was measured using multielectrode array recordings. Results: Our results demonstrate that the p.Y1816C variant leads to impaired SORLA maturation and reduced shedding, without affecting neuronal or organoid differentiation. Notably, we show an ultrastructure of endosomes, including their content, and demonstrate that both KO and KI models exhibit early endosome enlargement, increased APP retention in endosomes, elevated Aβ40/42 secretion, and amyloid-β deposition in 3D organoids. Importantly, we identified previously uncharacterized functional consequences of abolished SORLA activity, including axonal swellings and significantly impaired transport of Rab5+ endosomes and APP, characterized by deregulated velocities, directionality of transport, and increased stalling. Additionally, we discovered that both KO and p.Y1816C KI neurons exhibit abnormal electrophysiological activity, including increased spontaneous firing, burst frequency, and network synchrony. Conclusions: Our study defines the mechanistic consequences of the SORL1 p.Y1816C variant and demonstrates its pathogenicity in human neurons. Importantly, we also identify novel roles for SORLA in maintaining axonal transport homeostasis and regulating neuronal excitability, expanding its functional relevance beyond endosomal APP processing. These findings reinforce the central role of endosomal trafficking disruption in AD and support the use of isogenic human models for evaluating AD risk variants.
- Open Access
- 5 March 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (4) , 107137
Swedish Alzheimer’s disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways
- 5 March 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (4) , 107137
Open AccessSwedish Alzheimer’s disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
GENESIS OF AXONAL SWELLINGS IN TRAUMATIC INJURY
Background: Axonal swellings (AxS) are focal enlargements of axons found in a range of biological and pathological settings, including traumatic brain injury. However, the development of AxS and their early effects on axonal homeostasis are poorly understood. Here, we describe the cytoskeletal changes, transport effects and the molecular events that occur in the axon immediately after a traumatic injury.Method: We developed an in vitro system to study in real‐time the effects of traumatic injury on the axon of mature human neurons. We also generated an algorithm which allowed us to assess the dynamics of the AxS formation in real‐time and examine the role of Ca2+ in the swellings. Through mass spectrometry analysis on isolated axons we described the axonal proteome and identified the immediate phosphorylation changes ocurring in the axon after a traumatic injury. We also used superresolution microscopy to characterize the earliest cytoskeletal changes in the axon and their impact on the movement of several axonal cargoes.Result: As a result of the mechanical stress we observed the appereance of AxS, which were temporally correlated to Ca2+ levels increase in the axon. Interestingly, by pharmacologically blocking different sources of Ca2+ we observed that Ca2+ plays a role in sustaining the AxS and not in their formation. Proteomic and phosphoproteomic analysis revealed a significant regulation in proteins related to axon development after injury. These proteins were mainly interactors or components of the cytoskeleton, while no association to axonal degeneration or impairment in normal processes was found. We also predicted a general increase in kinases activity after injury, among them ROCK, ERK, JNK, PKC and GSK. A detailed analysis of cytoskeletal arrangement revealed modifications in the actin‐spectrin periodic structure and a mesh‐like organization of microtubules and neurofilaments in the AxS. We finally observed that the structure of swellings allows cargos to cross and that axonal transport of different cargos were not interrupted during mechanical stress.Conclusion: These observations indicate that the mechanical stress to the axon generates segments of cytoskeletal reorganization that result from Ca2+ increase and correlate with regulation through phosphorylation of cytoskeletal and cytoskeletal interacting proteins.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Open AccessGENESIS OF AXONAL SWELLINGS IN TRAUMATIC INJURY
Background: Axonal swellings (AxS) are focal enlargements of axons found in a range of biological and pathological settings, including traumatic brain injury. However, the development of AxS and their early effects on axonal homeostasis are poorly understood. Here, we describe the cytoskeletal changes, transport effects and the molecular events that occur in the axon immediately after a traumatic injury.Method: We developed an in vitro system to study in real‐time the effects of traumatic injury on the axon of mature human neurons. We also generated an algorithm which allowed us to assess the dynamics of the AxS formation in real‐time and examine the role of Ca2+ in the swellings. Through mass spectrometry analysis on isolated axons we described the axonal proteome and identified the immediate phosphorylation changes ocurring in the axon after a traumatic injury. We also used superresolution microscopy to characterize the earliest cytoskeletal changes in the axon and their impact on the movement of several axonal cargoes.Result: As a result of the mechanical stress we observed the appereance of AxS, which were temporally correlated to Ca2+ levels increase in the axon. Interestingly, by pharmacologically blocking different sources of Ca2+ we observed that Ca2+ plays a role in sustaining the AxS and not in their formation. Proteomic and phosphoproteomic analysis revealed a significant regulation in proteins related to axon development after injury. These proteins were mainly interactors or components of the cytoskeleton, while no association to axonal degeneration or impairment in normal processes was found. We also predicted a general increase in kinases activity after injury, among them ROCK, ERK, JNK, PKC and GSK. A detailed analysis of cytoskeletal arrangement revealed modifications in the actin‐spectrin periodic structure and a mesh‐like organization of microtubules and neurofilaments in the AxS. We finally observed that the structure of swellings allows cargos to cross and that axonal transport of different cargos were not interrupted during mechanical stress.Conclusion: These observations indicate that the mechanical stress to the axon generates segments of cytoskeletal reorganization that result from Ca2+ increase and correlate with regulation through phosphorylation of cytoskeletal and cytoskeletal interacting proteins.
- Open Access
Familial Alzheimer’s disease mutation undermines axonal transport by enhancing dynactin recruitment to the APP motor assemblies
Experiments in flies, mice and humans suggest a significant role of impaired axonal transport in the pathogenesis of Alzheimer’s disease (AD), however, the underlying mechanisms remain unknown 1,2 . We report that the Swedish familial AD (FAD) mutation perturbs fast anterograde axonal transport of the amyloid precursor protein (APP) by altering directionality of its movement. APP thus spends more time in retrograde movement and accumulates in the soma. We found that the Swedish mutation enhances recruitment of dynactin 1 to the APP transport assemblies. Given that dynactin 1 activates the retrograde motor dynein 3 , this hampers physiological anterograde axonal transport of APP. We last show that the Swedish mutation perturbs also the axonal transport of early endosomes, which rely on the same molecular motors as APP. Our findings reveal extensive impairment of the axonal transport pathways by a FAD mutation, which reflects dysregulation of the cargo motor assemblies.
Open AccessFamilial Alzheimer’s disease mutation undermines axonal transport by enhancing dynactin recruitment to the APP motor assemblies
Experiments in flies, mice and humans suggest a significant role of impaired axonal transport in the pathogenesis of Alzheimer’s disease (AD), however, the underlying mechanisms remain unknown 1,2 . We report that the Swedish familial AD (FAD) mutation perturbs fast anterograde axonal transport of the amyloid precursor protein (APP) by altering directionality of its movement. APP thus spends more time in retrograde movement and accumulates in the soma. We found that the Swedish mutation enhances recruitment of dynactin 1 to the APP transport assemblies. Given that dynactin 1 activates the retrograde motor dynein 3 , this hampers physiological anterograde axonal transport of APP. We last show that the Swedish mutation perturbs also the axonal transport of early endosomes, which rely on the same molecular motors as APP. Our findings reveal extensive impairment of the axonal transport pathways by a FAD mutation, which reflects dysregulation of the cargo motor assemblies.
- Open Access
- 21 September 2022
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 10 (1) , 1-27
Unraveling axonal mechanisms of traumatic brain injury
Axonal swellings (AS) are one of the neuropathological hallmark of axonal injury in several disorders from trauma to neurodegeneration. Current evidence proposes a role of perturbed Ca2+ homeostasis in AS formation, involving impaired axonal transport and focal distension of the axons. Mechanisms of AS formation, in particular moments following injury, however, remain unknown. Here we show that AS form independently from intra-axonal Ca2+ changes, which are required primarily for the persistence of AS in time. We further show that the majority of axonal proteins undergoing de/phosphorylation immediately following injury belong to the cytoskeleton. This correlates with an increase in the distance of the actin/spectrin periodic rings and with microtubule tracks remodeling within AS. Observed cytoskeletal rearrangements support axonal transport without major interruptions. Our results demonstrate that the earliest axonal response to injury consists in physiological adaptations of axonal structure to preserve function rather than in immediate pathological events signaling axonal destruction.
- 21 September 2022
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 10 (1) , 1-27
Open AccessUnraveling axonal mechanisms of traumatic brain injury
Axonal swellings (AS) are one of the neuropathological hallmark of axonal injury in several disorders from trauma to neurodegeneration. Current evidence proposes a role of perturbed Ca2+ homeostasis in AS formation, involving impaired axonal transport and focal distension of the axons. Mechanisms of AS formation, in particular moments following injury, however, remain unknown. Here we show that AS form independently from intra-axonal Ca2+ changes, which are required primarily for the persistence of AS in time. We further show that the majority of axonal proteins undergoing de/phosphorylation immediately following injury belong to the cytoskeleton. This correlates with an increase in the distance of the actin/spectrin periodic rings and with microtubule tracks remodeling within AS. Observed cytoskeletal rearrangements support axonal transport without major interruptions. Our results demonstrate that the earliest axonal response to injury consists in physiological adaptations of axonal structure to preserve function rather than in immediate pathological events signaling axonal destruction.